BEAM UP market verdict | Ezbrisk

Published: 1785884307495

Anomaly score: 0.0

Confidence: 0.65

Market summary

BEAM rallies on Q2 filing

Ezbrisk assessment

Beam Therapeutics filed its Q2 2026 10-Q today and the stock rallied sharply, though the filing itself contained no analyst consensus data to judge beats or misses, so the move likely reflects broader sentiment around its base editing platform progress rather than specific financial surprises.

Sources: https://www.sec.gov/Archives/edgar/data/1745999/000119312526331541/beam-20260630.htm

Verdict ID: a10b1b1c-b8f9-4617-aa64-3773970e281e